Awards/COOPERATIVE AGREEMENT (B)

$195,493,771

Department of Health and Human Services·Centers for Disease Control and Prevention

ACTION DATE2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_NU50CK000497_075

Award description

CK19-1904 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES (ELC)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds CDC epidemiology and laboratory capacity to detect, prevent, and control emerging infectious diseases across states.

Sub-sectors

public-healthinfectious-disease-surveillanceepidemiology-capacity

Why this matters

Strengthens U.S. disease surveillance infrastructure and rapid response capability for pandemic preparedness and outbreak control.

Supply-chain signal

Drives demand for diagnostic equipment, laboratory reagents, sequencing technology, and public health IT systems.

U.S.–China competition angle

Enhances U.S. biosecurity and disease detection independence; reduces reliance on foreign diagnostic capabilities during health emergencies.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002215.

Period of performance

Start

2019-08-01

End

2027-07-31

Status

activein 441 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_NU50CK000497_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.